Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00014261
Status:
COMPLETED
Last Update Posted:
2018-03-30
First Post:
2001-04-10
Brief Title:
Temozolomide Plus PEG-Interferon Alfa-2B in Treating Patients With Advanced Solid Tumors
Sponsor:
Dartmouth-Hitchcock Medical Center
Organization:
Dartmouth-Hitchcock Medical Center
Organization Data
Organization:
Dartmouth-Hitchcock Medical Center
Class:
OTHER
Study ID:
CDR0000068523
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Dartmouth-Hitchcock Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
LionelDLewis MD
Responsible Party Title:
Professor of Medicine and of Pharmacology and Toxicology
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Dartmouth-Hitchcock Medical Center
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |